TALIS BIOMEDICAL CORP (TLIS)
US87424L2079 - Common Stock
TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023
Talis Biomedical just reported results for the fourth quarter of 2023.
TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Talis Biomedical (NASDAQ:TLIS) just reported results for the fourth quarter of ...
Talis reviewing strategic alternatives, stock rallies 35% (TLIS)
Talis Biomedical (TLIS) stock soared 35% after the company announced it was cutting its workforce by 90% and reviewing strategic alternatives. Read more here.
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health...
7 Small-Cap Stocks to Sell in August Before They Crash and Burn
There’s a time to buy and there’s a time to red flag small-cap stocks to avoid in August before they sink your portfolio.
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health...
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
Talis Biomedical regains compliance with Nasdaq's minimum bid price rule (NASDAQ:TLIS)
Diagnostic company Talis Biomedical (TLIS) said on Monday that it has regained compliance with Nasdaq's minimum bid price requirement of at least $1.00 per share.
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Talis Biomedical Announces 1-for-15 Reverse Stock Split
Talis Biomedical Announces 1-for-15 Reverse Stock Split
REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health...
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Wednesday morning!
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific...
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023
REDWOOD CITY, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health...
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
REDWOOD CITY, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health...